Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of inhaled peramivir for uncomplicated influenza in adults
CTR20244827Phase 3Active
- Sponsor
- Nanxin Pharmaceutical
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in influenza, Influenza A infection, influenza B, sponsored by Nanxin Pharmaceutical. Started Dec 2024; status: active.
02
Drugs
peramivir
03
Conditions
influenzaInfluenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20244827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244827.